NovaBridge Biosciences Fair Value Adjustment of Warrants
NovaBridge Biosciences (NBP) reported Fair Value Adjustment of Warrants of CNY 0 for the 12-month period ending 2021-12-31, per its 20-F filed 2022-04-29.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2022-04-29
- NovaBridge Biosciences fair value adjustment of warrants for the quarter ending 2019-12-31 was -35.00K CNY.
CNY
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|
| 2021-12-31 | 0.00 CNY 20-F · filed 2022-04-29 | ||
| 2020-12-31 | 0.00 CNY 20-F · filed 2022-04-29 | ||
| 2019-12-31 | -35.00K CNY derived: 20-F 12 month − 6-K 9 month · filed 2022-04-29 | -5.64M CNY 20-F · filed 2022-04-29 | |
| 2019-09-30 | -5.61M CNY 6-K · filed 2021-02-05 | ||
| 2018-12-31 | -61.41M CNY 20-F · filed 2021-04-28 | ||
| 2017-12-31 | 14.03M CNY 20-F · filed 2020-04-29 |
USD
| Period end | Fair Value Adjustment of Warrants 12 month |
|---|---|
| 2021-12-31 | $0.00 20-F · filed 2022-04-29 |
| 2019-12-31 | -$811.00K 20-F · filed 2020-04-29 |